Bisi Bright is a Consultant Clinical Pharmacist, Lecturer, and Public Health Manager. She is 1st Vice Chairman and CEO of LiveWell Initiative LWI, a self-sustaining nonprofit healthcare social enterprise.
Appointed a Practicum Preceptor for MPH and DrPH candidates at the prestigious Harvard T H Chan School of Public Health in Boston USA, she sat on the Faculty of the Economist Conferences’ Healthcare in Africa; and also served on the Africa Regional Steering Committee of the IAPO (International Alliance for Patients’ Organisations) from 2009-2012.
Bisi Bright was the first black African Honoree to be recognized as GLOBAL CHANGEMAKER2017 IN HEPATITIS C, by the EIU (Economist Intelligence Unit) (please see link at http://bit.ly/2xa665o ), and she received a Commendation Letter from the Presidency at Aso Rock Villa, Nigeria, for her work in Hepatitis.
Bisi has written well over 100 published articles, some of which are in peer-reviewed journals, and is a Doctoral Thesis Supervisor at the University of Helsinki, Finland. She is a two-time International Award winner of the IATDM/CT and a winner of other Awards - local and international.
She is Deputy National Coordinator of the National Hepatitis Coalition in Nigeria:
- In September 2016 she was among the 25 Top Women in Hepatitis worldwide, invited to the WIHP (Women in High Places) Hepatitis Meeting in New York
- In April 2017 she founded the WOMEN IN HEPATITIS AFRICA, the voice of the women of Africa, joining hands to eliminate viral hepatitis by 2030.
Bisi has taken Hepatitis Awareness and Sensitization programmes into corporate board rooms, corporate entities, and to a vast population at the base of the pyramid, as well as the academia where the organization is currently co-supervising Doctoral research with strong Hepatitis Content. In January 2019, the organization launched its Women Wellness Center for Hepatitis WWC-H at the Sogunro Waterfront in low-income riverine Lagos.
Since the advent of COVID-19 her organisation LWI has been busy researching into the use of 4-Aminoquinolines in COVID-19 Respnse, and has obtained Research and Ethics Committee Approval. While awaiting Clinical Trial approvals at the national and regional levels, the LWI Clinical Research Team has published 4 peer reviewed articles in open access international journals showcasing the effectiveness of the LWI Study Protocols, for COVID-9 Response in Africa.
The organisation, along with its subsidiary Women In Hepatitis Africa, embarked on PMTCT Project in 2019 as a commemoration for World Hepatitis Day, by adopting a Policy to screen every pregnant woman for viral hepatitis. The advocacy for Birth Dose vaccination against hepatitis B, is a core project which Bisi has vigorously pursued and embraced, with great passion.
Bisi serves as a Board Member of the International Alliance of Patients Organisations IAPO - a member of the British Charities Trust; and as a Patient Expert, she is passionate about the Patient Cause.
